Drugs / MH004 Ointment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07181187 | Mar 2024 → Sep 2025 | vitiligo | Minghui Pharmaceutical (Hangzhou) Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MH004 Ointment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07181187 ↗ |
| Route | Topical | “MH004 1% ointment applied topically to the affected area as a thin film once or twice daily.” NCT07181187 ↗ |